Differential metabolism of ApoE isoforms in plasma and CSF - PubMed (original) (raw)

Review

Differential metabolism of ApoE isoforms in plasma and CSF

Suzanne E Wahrle et al. Exp Neurol. 2003 Sep.

No abstract available

PubMed Disclaimer

Comment on

• APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
  Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC. Fukumoto H, et al. Exp Neurol. 2003 Sep;183(1):249-53. doi: 10.1016/s0014-4886(03)00088-8. Exp Neurol. 2003. PMID: 12957508

Similar articles

• Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
  Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM. Martínez-Morillo E, et al. Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15. Acta Neuropathol. 2014. PMID: 24633805
• Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
  Miida T, Yamada T, Seino U, Ito M, Fueki Y, Takahashi A, Kosuge K, Soda S, Hanyu O, Obayashi K, Miyazaki O, Okada M. Miida T, et al. Biochim Biophys Acta. 2006 Apr;1761(4):424-33. doi: 10.1016/j.bbalip.2006.03.013. Epub 2006 Apr 17. Biochim Biophys Acta. 2006. PMID: 16651021
• Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
  Fagan AM, Holtzman DM. Fagan AM, et al. Microsc Res Tech. 2000 Aug 15;50(4):297-304. doi: 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C. Microsc Res Tech. 2000. PMID: 10936884 Review.
• Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.
  Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP. Mehta PD, et al. Neurosci Lett. 2001 May 18;304(1-2):102-6. doi: 10.1016/s0304-3940(01)01754-2. Neurosci Lett. 2001. PMID: 11335065

Cited by

• DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
  Shao Y, Shaw M, Todd K, Khrestian M, D'Aleo G, Barnard PJ, Zahratka J, Pillai J, Yu CE, Keene CD, Leverenz JB, Bekris LM. Shao Y, et al. J Hum Genet. 2018 Apr;63(4):459-471. doi: 10.1038/s10038-017-0393-8. Epub 2018 Jan 25. J Hum Genet. 2018. PMID: 29371683 Free PMC article.
• Effect of domain interaction on apolipoprotein E levels in mouse brain.
  Ramaswamy G, Xu Q, Huang Y, Weisgraber KH. Ramaswamy G, et al. J Neurosci. 2005 Nov 16;25(46):10658-63. doi: 10.1523/JNEUROSCI.1922-05.2005. J Neurosci. 2005. PMID: 16291938 Free PMC article.
• Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
  Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM. Wahrle SE, et al. Mol Neurodegener. 2007 Apr 12;2:7. doi: 10.1186/1750-1326-2-7. Mol Neurodegener. 2007. PMID: 17430597 Free PMC article.
• apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
  Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. Deane R, et al. J Clin Invest. 2008 Dec;118(12):4002-13. doi: 10.1172/JCI36663. Epub 2008 Nov 13. J Clin Invest. 2008. PMID: 19033669 Free PMC article.
• Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort.
  Rasmussen KL, Tybjærg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Rasmussen KL, et al. Eur Heart J. 2019 Sep 1;40(33):2813-2824. doi: 10.1093/eurheartj/ehz402. Eur Heart J. 2019. PMID: 31236578 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal